Introduction {#s2}
============

Nystagmus is a common symptom of a range of diseases including at least three X-linked disorders, with one of those being ocular albinism type 1 (OA1; MIM 300500) mapped to Xp22.3 [@pone.0043177-Bassi1]. It should be distinguished from the congenital motor nystagmus (CMN), a hereditary disorder characterized by bilateral ocular oscillations that occurs in the absence of any obvious ocular disorders [@pone.0043177-Kerrison1]. Identification of the underlying disease of CMN often requires extensive clinical, electrophysiological, psychophysical, and eventually molecular genetic examinations, especially when clinical findings are unrevealing [@pone.0043177-Charles1], [@pone.0043177-Faugere1]. The prevalence of X-linked OA1 is estimated to be 1 in 50,000 live births. Most male patients with OA1 showed normal skin and hair pigment, but will usually have signs and symptoms of ocular albinism, including nystagmus, poor visual acuity, iris translucency, foveal hypoplasia and albinotic fundus [@pone.0043177-Creel1], [@pone.0043177-Preising1]. However, the characteristics of OA1 have not been well defined in Asians. OA1 is caused by mutations in the G protein-coupled receptor 143 (*GPR143*) gene, originally also known as the *OA1* gene [@pone.0043177-Schiaffino1]. Various types of mutations in GPR143 have been identified in different countries, but X-linked OA1 in the Chinese population was rarely reported [@pone.0043177-Fang1].

In the present study, a five-generation Chinese family with OA1was recruited. All affected individuals exhibited nystagmus as the main symptom and failed to show photophobia, iris translucency and strabismus. This pedigree was initially considered as congenital nystagmus. Diagnosis of OA1was made by extensive clinical examinations. Four-point-one (4.1), ezrin, radixin, moesin (FERM) domain-containing 7 (*FRMD7* candidate gene for CMN) and G protein-coupled receptor 143 (*GPR143*, candidate gene for OA 1) genes were analyzed.

Methods {#s3}
=======

Family Recruitment {#s3a}
------------------

A five-generation Chinese family with OA1 was recruited in Sichuan ([Figure 1](#pone-0043177-g001){ref-type="fig"}). Written informed consent was obtained in accordance with the Declaration of Helsinki before blood samples were taken for analysis (see attachment for details). Three minors were used in this study. Written informed consent was obtained from the guardians on behalf of the minors (see attachment for details). This study was approved by both West China Hospital, Sichuan University Institute Review Board and North Sichuan Medical College Institute Review Board.

![The pedigree of X-linked OA1.\
A filled square indicates an affected male and a dot in the middle of the circle indicates a carrier. The proband is marked by an arrow. The underline indicates family members enrolled in this study.](pone.0043177.g001){#pone-0043177-g001}

Clinical Examination {#s3b}
--------------------

Complete physical examination and detailed ophthalmological examination were carried out on the subjects of this family, including 4 affected patients, 7 carriers and some asymptomatic individuals. Visual acuity (VA) was measured using the best-corrected Snellen visual acuity test. Fundus and OCT examinations were performed using fundus camera (nonmyd WX 3D, Kowa, Japan) and Spectralis OCT (Heidelberg Engineering, Germay).

Mutation Screening and Sequence Analysis {#s3c}
----------------------------------------

Genomic DNA was extracted from 200 µl of peripheral blood using the standard phenol/chloroform method. DNA integrity was evaluated by 1% agarose gel electrophoresis.

Mutation analysis of *FRMD7* and *GPR143* was performed using PCR and direct sequencing. Primers were designed to cover the sequences of all coding exons of the genes, according to published primer sequences with some modification ([Table 1](#pone-0043177-t001){ref-type="table"}) [@pone.0043177-Schorderet1], [@pone.0043177-Peng1]. The primers were synthesized by Invitrogen (Carlsbad, CA, USA). PCRs were carried out in a MyCycler thermocycler (Bio-Rad, Hercules, CA, USA) using the following program: initial denaturation at 95°C for 2 min followed by 35 cycles of 94°C for 10s, 54°C--56°C for 30s, and 72° for 1 min, and then a final extension at 72°C for 5 min.

PCR products were directly sequenced using an ABI 377XL automated DNA sequencer (Applied Biosystems, Foster City, CA), and analyzed with the DNAStar (Madison, WI) software and compared with the published *FRMD7* and *GPR143* sequences. Mutation was named according to the nomenclature recommended by the Human Genomic Variation Society (HGVS).

10.1371/journal.pone.0043177.t001

###### Primers used in PCR for amplification of *FRMD7* and *GPR143*.

![](pone.0043177.t001){#pone-0043177-t001-1}

  Exon     Primer direction      Sequence (5′→3′)      Annealing temperature (°C)   Product size (bp)
  ------- ------------------ ------------------------ ---------------------------- -------------------
  1            FRMD7-1F        GAGAAAGCACCCACAGCACT                56                      229
               FRMD7-1R       CAGTCCTCCTTCATTCAGTCC                                
  2            FRMD7-2F       TGTGGCTTCTACCCTTTATTC                54                      403
               FRMD7-2R        AGTGTTGGGATTACAGGCAT                                
  3            FRMD7-3F       TGGAGCAGTGATTCAAATGTC                54                      336
               FRMD7-3R       TCTAACTGTGAACTCTCTTCCT                               
  4            FRMD7-4F       CCTATAACTGTTGTGATGGAC                54                      260
               FRMD7-4R       CATCTCCCAGACAGTGACTTA                                
  5            FRMD7-5F        TGCCAAAGTGTTCAATCAGC                54                      368
               FRMD7-5R        CTCCTGTGCTTGGTTCTCTA                                
  6+7          FRMD7-6F        TGGAGGACAAGGGTATGCT                 55                      642
               FRMD7-6R       GTGATAATACTGAGGGGTGAG                                
  8            FRMD7-7F        GACCACAGCTCCTACCCAGT                56                      374
               FRMD7-7R       AAAGACACACCATCACTCAGG                                
  9            FRMD7-8F       GAGCAATAGTTTGGAAGGCAT                54                      293
               FRMD7-8R       AAGAAGCAGTGTGAGCAGTTT                                
  10+11        FRMD7-9F        TGTTCTCTGCCTGGTCCTTG                55                      532
               FRMD7-9R        TTTACACACTGGGATTCTGG                                
  12          FRMD7-10F       CTACCCTAGAATAGAACATGGA               54                      702
              FRMD7-10R        ATTCCTTGGGCTTCTTTCAG                                
  12          FRMD7-11F        GGAAAGGACAAGTCCACATA                54                      660
              FRMD7-11R        TTCTGCCTAAGTCGGTAACA                                
  1             GPR-1F         AACCTTCCCAACCTTTCTGC                55                      698
                GPR-1R         CCTCTCGTCCTCACTCCATC                                
  2             GPR-2F        CAGTGAGCAGGGTTTTTACCA                55                      537
                GPR-2R         AACAGACTCCCAGGGTTTGC                                
  3             GPR-3F         GTCTACCCTGCCGTCTCAAG                56                      334
                GPR-3R         TGAGCTGCTGTGGATGTTTC                                
  4             GPR-4F         CTCAGCAGCACGAGGAAACT                56                      465
                GPR-4R         ACAAACGAGAAAGGCAGAGC                                
  5             GPR-5F         CTTAGGGGTCCTCCCATTTC                55                      575
                GPR-5R         TGGCACTGAGCTAACAAACG                                
  6             GPR-6F        TCAGTGACTTGCTTTGCTTCCT               54                      387
                GPR-6R         TCCTCAAAGGGCACCTAGCA                                
  7             GPR-7F         GCACCTGGCCCTCTTAGTTT                55                      458
                GPR-7R        ACCTGTAGTCCCAGTTACTCA                                
  8             GPR-8F         ATGGTCCCTTCCAAGCGAGT                56                      494
                GPR-8R        GTTCACATGAGAGGTGCTGCT                                
  9             GPR-9F        ACTCCATGCACTGAATACTGA                54                      485
                GPR-9R        GGATGTGGACCTTACACTTACT                               

Results {#s4}
=======

Clinical Phenotype {#s4a}
------------------

In this five-generation Chinese family, the disease was transmitted from female carrier to affected son, indicating that the disease was inherited in an X-linked recessive pattern ([Figure 1](#pone-0043177-g001){ref-type="fig"}). The clinical characteristics of OA1 in this pedigree are described as in [Table 2](#pone-0043177-t002){ref-type="table"}, [Figure 2](#pone-0043177-g002){ref-type="fig"} and [3](#pone-0043177-g003){ref-type="fig"}.

Reduced Visual Acuity and Nystagmus {#s4b}
-----------------------------------

All four patients presented with nystagmus and reduced visual acuity (corrected visual acuity of 0.01--0.2). The nystagmus was present during their first three months after birth. Eye movement recording revealed that the patients had conjugate horizontal nystagmus. The proband (patient III:30, [Figure 1](#pone-0043177-g001){ref-type="fig"}), a forty-two-year-old male, presented with nystagmus with best corrected visual acuity being 0.2 OD and 0.2 OS. He presented with nystagmus and congenital cataract on the fortieth day after birth and underwent cataract extraction and intraocular lens implantation at the age of 41. No pigmentation abnormality of skin and hair was observed in the participants. Ocular abnormalities were not found in other asymptomatic members examined in this family.

Presence of Hypopigmentation in the Fundus and Foveal Hypoplasia {#s4c}
----------------------------------------------------------------

Compared with normal individuals ([Figure 2](#pone-0043177-g002){ref-type="fig"}, I, J), the patients (III:19, IV:19) exhibited an albinotic fundus ([Figure 2](#pone-0043177-g002){ref-type="fig"}, A, B, C, D, E, F). All of the patients had foveal hypoplasia. The OCT showed extension of all neurosensory retinal layers through the area in which the fovea would normally be located ([Figure 3](#pone-0043177-g003){ref-type="fig"}). The clinical features of affected males and female carriers were shown in [Table 2](#pone-0043177-t002){ref-type="table"}.

10.1371/journal.pone.0043177.t002

###### Summary of clinical features of affected males and female carriers.

![](pone.0043177.t002){#pone-0043177-t002-2}

  ID          Gender   Age   Visual acuity (left/right)   Iris hypopigmentation   Fundus hypopigmentation    Fundus foveal hypoplasia   Nystagmus     Mutation
  ---------- -------- ----- ---------------------------- ----------------------- -------------------------- -------------------------- ----------- --------------
  patients                                                                                                                                         
  III:19       Male    47             0.05/0.1                     No                       Yes                        Yes                 Yes       hemizygous
  III:21       Male    47            0.01/0.01                     No                       Yes                        Yes                 Yes       hemizygous
  III:30       Male    42             0.2/0.2                     Mild                       No                        Yes                 Yes       hemizygous
  IV:19        Male    21             0.1/0.1                      No                       Yes                        Yes                 Yes       hemizygous
  Carriers                                                                                                                                         
  II6         Female   78            0.05/0.05                     No             Cataract, Unclear fundus   Cataract, Unclear fundus      No       heterozygous
  II:10       Female   64             0.8/0.8                      No                        No                         No                 No       heterozygous
  II:12       Female   62             0.6/0.6                      No                        No                         No                 No       heterozygous
  III:18      Female   55             0.7/0.7                      No                        No                         No                 No       heterozygous
  III:24      Female   44             0.8/0.8                      No                        No                         No                 No       heterozygous
  IV:16       Female   20     1.0/1.0 (best corrected)             No                Yes (High myopia)                  No                 No       heterozygous
  IV:17       Female   24             0.8/0.8                      No                        No                         No                 No       heterozygous

*GPR143* Mutation Identification and Analysis {#s4d}
---------------------------------------------

A novel nonsense mutation, c.807T\>A, at codon 807 (TAT to TAA) of exon 7 in *GPR143* gene was identified in all affected males. This mutation was presented as heterozygous in all obligate female carriers, and it was not found in normal members of the family. The c.807T\>A mutation caused a substitution of tyrosine leading to a premature termination codon at position 269 (p.Y269X) of GPR143 protein.

Discussion {#s5}
==========

A Chinese family with "congenital" nystagmus as the main symptom was reported in this study. There is no difference in iris pigmentation between patients (except the proband) or carriers and normal individuals in this family. The patients presented with only mild hypopigmentation in fundus. The presence of foveal hypoplasia could be ignored since the macular morphology could not be easily obtained by OCT due to the poor fixation of the nystagmus eye of the patients. Therefore this Chinese family was considered originally as congenital nystagmus. Preising *et al.* reported that nystagmus, macular hypoplasia and hypopigmentation of the fundus were the characteristic signs of ocular albinism which are more reliable in identifying patients with albinism [@pone.0043177-Preising1], [@pone.0043177-Preising2].

For the molecular diagnosis of this pedigree, the *FRMD7* gene (candidate gene for congenital nystagmus) and *GPR143* gene (candidate gene for OA1) were analyzed. The sequence analysis of *GPR143* demonstrated a novel nonsense mutation (p.Y269X) in exon 7. All affected males were hemizygous for the mutation and female carriers were heterozygous for the mutation whereas the other normal members of the family had no mutation. Another gene, *FRMD7*, involved in the development of congenital nystagmus, was screened and no mutation was found. Thus, the results of clinical and genetic findings provide solid evidence showing that this Chinese family has X-linked OA1, and the p.Y269X mutation of *GPR143* is responsible for the pathogenesis.

![Fundus photographs of three patients, one carrier and one normal individual.\
A--F: three patients; G--H: one carrier; I--J: one normal individual.](pone.0043177.g002){#pone-0043177-g002}

Bassi *et al.* (1995) cloned *GPR143* gene for ocular albinism type 1 from the distal short arm of the X chromosome [@pone.0043177-Bassi1]. Also in 1995, Schiaffino *et al.* screened *GPR143* gene and detected various mutations in one-third of X-linked ocular albinism (XLOA) patients [@pone.0043177-Schiaffino1]. To date, about one hundred mutations of *GPR143* were deposited in Human Gene Mutation Database (HGMD), including deletion, frameshift, and nonsense mutations. Most of *GPR143* mutations were reported in a large collection of patients mainly with ocular albinism [@pone.0043177-Camand1], [@pone.0043177-Schnur1], [@pone.0043177-dAddio1], [@pone.0043177-Oetting1]. In 2001, Preising *et al.* reported an X-linked CN family with ocular albinism and found 14 bp deletion in *GPR143* gene [@pone.0043177-Preising1]. In 2007, Liu *et al.* identified a novel missense *GPR143* mutation in a large Chinese family with CN as the most prominent and consistent manifestation [@pone.0043177-Liu1]. In more recent years, *GPR143* mutations have been identified in the other two Chinese families with X -linked CN without any classical phenotype of OA1. One family had a 37 bp deletion mutation in exon 1 of *GPR143* [@pone.0043177-Zhou1]. The other family had a 19 bp duplication in exon 1 of *GPR143* and all affected individuals exhibited nystagmus [@pone.0043177-Peng1]. These two reports did not present sufficient clinical data to evaluate their hypothesis of isolated nystagmus from *GPR143* variants. Preising *et al.* suggested male patients with congenital nystagmus were candidates for X-linked OA and a thorough clinical examination was needed [@pone.0043177-Preising2]. Furthermore, analysis of the *FRMD7* and *GPR143* genes would be helpful to distinguish these two conditions from the molecular level.

![OCT test photographs of three patients, one carrier and one normal individual.\
A--F: three patients; G--H: one carrier; I--J: one normal individual. It should be noted that detailed structural imaging of the fovea was not successfully obtained in two patients (III:19 and III:30) with more severe nystagmus due to their poor fixation. Foveal image of one patient (IV:19) with relatively mild nystagmus was obtained.](pone.0043177.g003){#pone-0043177-g003}

*GPR143* on chromosome Xp22.3 contains 9 exons and encodes a protein of 404 amino acids containing seven putative transmembrane domains and one potential N-glycosylation site using an asparagine at codon 106 [@pone.0043177-Mayeur1]. *GPR143* protein is a conserved integral membrane protein that has weak similarities to G protein-coupled receptors (GPCRs), which participate in the most common signal transduction system at the plasma membrane. It binds heterotrimeric G proteins, which suggests that *GPR143* GPCR-mediated signal transduction systems also operate at the internal membranes in mammalian cells [@pone.0043177-Schiaffino2]. The p.Y269X mutation identified in our study was predicted to result in a truncated protein with 269 amino acids shorter than the normal full-length protein, suggesting that this is a loss-of-function mutation. Furthermore, the mutated transcript is likely to be degraded by the nonsense-mediated mRNA decay (NMD) pathway. This hypothesis assumed that the truncated protein may not even be produced.

It is unclear how the mutated *GPR143* causes the ocular abnormalities, such as macular hypoplasia in people with ocular albinism. Lopez *et al.* proposed that L-3, 4-dihydroxyphenylalanine (L-DOPA) might be a ligand for the protein encoded by *GPR143* [@pone.0043177-Lopez1]. L-DOPA is a precursor in melanin synthesis that has been considered as an antimitogenic factor in cell cycle regulation, playing a crucial role in the maturation of the retina and the optic nerve [@pone.0043177-Ilia1], [@pone.0043177-Ilia2]. *GPR143* is not involved in the production of melanin itself, but rather the pigment distribution or production of a precursor like L-DOPA as a cause of developmental anomalies of macular development. The impaired macular development might then cause the vision loss and nystagmus [@pone.0043177-Preising2], as reported in this study.

The ocular disorders should be eliminated before the diagnosis of congenital motor nystagmus can be made. However, some diseases such as OA1 can be ignored or misdiagnosed. In general, OA1 is characterized by presence of photophobia, congenital nystagmus, strabismus, iris translucency, hypopigmentation of the ocular fundus, foveal hypoplasia, and impaired vision [@pone.0043177-Rosenberg1]. In African-American males, iris color is usually brown with little iris translucency (compared to Caucasians where iris translucency is more common) and individuals with darker skin may have scattered hypopigmented macules, but this is rarely seen in the skin of Caucasian individuals [@pone.0043177-ODonnell1], [@pone.0043177-ODonnell2]. The characteristics of OA1 have not been well defined in Asians. There were Chinese pedigrees of congenital nystagmus reported showing that the patients in these families had very similar symptoms as those in our pedigree. It is interesting to reevaluate these pedigree to make sure the diagnosis of "congenital nystagmus", not "ocular albinism", is correct, and the impression that OA1 has rarely seen in China is correct.

In summary, this study adds a novel nonsense mutation to the existing spectrum of *GPR143* mutations in Chinese families with X-linked OA1. The specific molecular mechanism by which these *GPR143* mutations result in OA1 is still unknown, further functional studies are needed to provide new insights to this inherited ocular disease.

The authors are deeply grateful to all the family members of this pedigree for their cooperation in this study.
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